HIGHLIGHTS
- who: (C) et al. from the Department University of have published the research work: Infectious Diseases in Obstetrics and Gynecology 8:124-137 (2000), in the Journal: (JOURNAL) of 25/02/2000
- how: The authors studied the activity and mechanism of action of benzydamine lidocaine and bupivacaine against C. albicans and non-albicans strains. The present results show that the three drugs now studied could be used topically to treat mucosal or cutaneous candidosis because concentrations with antifungal activity can be obtained with the commercial formulations available mainly with benzydamine the most active of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.